Journal
Child's nervous system
Publication Date
11-1-2022
Volume
38
Issue
11
First Page
2245
Last Page
2249
Document Type
Open Access Publication
DOI
10.1007/s00381-022-05571-y
Rights and Permissions
Cantor, E., Meyer, A., Morris, S.M. et al. Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1. Childs Nerv Syst 38, 2245–2249 (2022). https://doi.org/10.1007/s00381-022-05571-y. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Cantor, Evan; Meyer, Ashley; Morris, Stephanie M; Weisenberg, Judith L Z; and Brossier, Nicole M, "Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1." Child's nervous system. 38, 11. 2245 - 2249. (2022).
https://digitalcommons.wustl.edu/oa_4/3131
Department
ICTS (Institute of Clinical and Translational Sciences)
